Reply to Willoughby.
Saved in:
| Title: | Reply to Willoughby. |
|---|---|
| Authors: | Holzbauer SM; Minnesota Department of Health, St. Paul, Minnesota, USA.; Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Schrodt CA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Prabhu RM; Essentia Health, Duluth, Minnesota, USA., Asch-Kendrick RJ; Midwest Medical Examiner's Office, Ramsey, Minnesota, USA., Ireland M; Minnesota Department of Health, St. Paul, Minnesota, USA., Klumb C; Minnesota Department of Health, St. Paul, Minnesota, USA., Firestone MJ; Minnesota Department of Health, St. Paul, Minnesota, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Liu G; Minnesota Department of Health, St. Paul, Minnesota, USA., Harry K; Minnesota Department of Health, St. Paul, Minnesota, USA., Levine MZ; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Orciari LA; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wilkins K; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ellison JA; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Zhao H; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Niezgoda M; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Satheshkumar PS; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Petersen BW; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Rao AK; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bell WR; University of Minnesota, Minneapolis, Minnesota, USA., Forrest S; Essentia Health, Duluth, Minnesota, USA., Gao W; Allina Health, The Commons at Midtown Exchange, Minneapolis, Minnesota, USA., Dasheiff R; Essentia Health, Duluth, Minnesota, USA., Russell K; Essentia Health, Duluth, Minnesota, USA., Wiseman A; Essentia Health, Duluth, Minnesota, USA., Reichard RR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Smith KE; Minnesota Department of Health, St. Paul, Minnesota, USA., Lynfield R; Minnesota Department of Health, St. Paul, Minnesota, USA., Scheftel J; Minnesota Department of Health, St. Paul, Minnesota, USA., Wallace RM; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bonwitt J; Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Sep 18; Vol. 77 (6), pp. 931-932. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
